Bausch + Lomb Corp (BLCO : TSX)
Common Stock
Follow BLCO
BLCO
Bausch + Lomb Corp
Performance
1 Day
-0.73%
1 Week
+1.49%
1 Month
+29.23%
YTD
+31.15%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$10.89B
52W High
$30.46
52W Low
$20.25
P/E Ratio
-
50 Day MA
$25.15
200 Day MA
$23.33
Beta
0.52
Dividend Yield
-
WA Score
How BLCO stacks up against 944 Canadian stocks
out of 99
- Value45
Not profitable over the last 12 months.
- Quality
- Momentum86
31.2% this year, above its 200-day average, 94% of the way up its 52-week range.
- Analysts
- Insiders
Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks
Performance history
BLCO returns since 2022
Bausch + Lomb Corp has traded since May 2022 in our data, with 2 up years out of 3 full calendar years. Its deepest fall was −50.0% (Dec 2024 to May 2025).
1 year / yr
+41.5%
3 years / yr
+11.3%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2022*−17.5%
- 2023+7.7%
- 2024+14.5%
- 2025−9.7%
- 2026*+27.5%
* Partial year (first year of data, or year to date).
$10,000 invested in BLCO
- 1 year ago$14,152
- 2022 (start of our data)$11,722
- Best year
- 2024: +14.5%
- Worst year
- 2025: −9.7%
- All-time high in our data
- $30 on Nov 11, 2026 · now −1.9%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), May 2022 to Nov 2026. Past returns do not predict future ones.
Earnings
BLCO earnings history
Bausch + Lomb Corp beat the EPS estimate in 2 of its last 4 reported quarters.
Next report
Feb 17, 2027 · before open
EPS estimate $0.37
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 30, 2026 | Oct 28, 2026 | $0.34 | $0.22 | +54.5% |
| Jun 30, 2026 | Jul 29, 2026 | $0.16 | $0.16 | +0.0% |
| Mar 31, 2026 | Apr 29, 2026 | $0.08 | $0.05 | +60.0% |
| Dec 31, 2025 | Feb 18, 2026 | $0.32 | $0.36 | −11.1% |
| Sep 30, 2025 | Oct 29, 2025 | $0.18 | $0.16 | +12.5% |
| Jun 30, 2025 | Jul 30, 2025 | $0.07 | $0.09 | −22.2% |
| Mar 31, 2025 | Apr 30, 2025 | −$0.07 | $0.02 | −450.0% |
| Dec 31, 2024 | Feb 19, 2025 | $0.25 | $0.23 | +6.8% |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past BLCO? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Bausch + Lomb Corp insider transactions
Open-market and private equity trades (last 12 months volume). Derivatives and opening balances excluded.
Recent transactions
| Date | Side | Name | Shares | Price |
|---|---|---|---|---|
| Oct 29, 26 | Sell | Munsch, Frederick John Individual · CA$2.3m | 112,015 | CA$20.48 |
| Oct 11, 26 | Sell | Saunders, Brenton Lawrence Individual | 2,488,644 | — |
| Oct 11, 26 | Sell | Saunders, Brenton Lawrence Individual | 541,971 | — |
| Oct 11, 26 | Sell | Saunders, Brenton Lawrence Individual | 2,559,586 | — |
| Aug 10, 26 | Sell | Munsch, Frederick John Individual · CA$8,365 | 500 | CA$16.73 |
| Aug 10, 26 | Sell | Munsch, Frederick John Individual · CA$2,037 | 121 | CA$16.84 |
| Aug 10, 26 | Sell | Munsch, Frederick John Individual · CA$39,332 | 2,344 | CA$16.78 |
| Aug 10, 26 | Sell | Munsch, Frederick John Individual · CA$25,148 | 1,500 | CA$16.77 |
| Aug 10, 26 | Sell | Munsch, Frederick John Individual · CA$3,354 | 200 | CA$16.77 |
| Aug 10, 26 | Sell | Munsch, Frederick John Individual · CA$22,603 | 1,343 | CA$16.83 |
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/16/2026 | $30.64 | $30.64 | $29.88 | $29.89 | $29.89 | 15,700 |
| 11/13/2026 | $30.17 | $30.32 | $29.98 | $30.11 | $30.11 | 1,207 |
| 11/12/2026 | $30.20 | $30.26 | $29.88 | $30.09 | $30.09 | 1,914 |
| 11/11/2026 | $30.32 | $30.46 | $30.21 | $30.46 | $30.46 | 1,162 |
| 11/10/2026 | $29.35 | $30.36 | $29.34 | $30.34 | $30.34 | 3,296 |
| 11/9/2026 | $28.36 | $29.45 | $28.24 | $29.45 | $29.45 | 3,724 |
| 11/6/2026 | $27.73 | $28.30 | $27.73 | $28.19 | $28.19 | 1,015 |
| 11/5/2026 | $28.61 | $28.79 | $27.91 | $27.96 | $27.96 | 2,401 |
| 11/4/2026 | $28.61 | $28.80 | $28.49 | $28.77 | $28.77 | 701 |
| 11/3/2026 | $27.86 | $27.98 | $27.86 | $27.98 | $27.98 | 600 |
Analyst Price Targets
Based on analyst covering BLCO · as of Nov 13, 2026
Wall Street analysts forecast BLCO stock price to fall 10.0% over the next 12 months.
Consensus
Moderately BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$26.90
-10.0% Upside
Previously C$26.68 on Nov 11, 2026
Current Price
C$29.89
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
56.6%
Annualized
90-Day Vol
38.7%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$35.73
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$31.72 | C$26.09 – C$38.57 |
| 60 trading days | C$33.67 | C$25.54 – C$44.39 |
| 90 trading days | C$35.73 | C$25.47 – C$50.13 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Bausch + Lomb Corp
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
Financials
- Revenue (TTM)
- $5.42B
- EBITDA
- $914.00M
- Profit Margin
- -2.05%
- ROE (TTM)
- -1.58%
- EPS (Diluted)
- -0.44
- Book Value
- 25.30
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About BLCO
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| HWO | High Arctic Energy Services Inc. | $1.74 | +29.85% |
| AAV | Advantage Oil & Gas Ltd. | $13.45 | +23.74% |
| LUC | Lucara Diamond Corp | $0.13 | +13.64% |
| T | Telus Corp | $13.70 | +12.85% |
| FRX | Fennec Pharmaceuticals Inc | $18.35 | +10.81% |
| KEL | Kelt Exploration Ltd. | $12.72 | +10.70% |
| NVO | Novo Resources Corp | $0.07 | +8.33% |
| ELO | Eloro Resources Ltd. | $1.23 | +7.89% |
Latest BLCO news
Wire stories from the last 10 days. Tap a headline for a preview.
Yahoo Finance · 3d ago
Free with a Wealth Awesome account
Keep analysing BLCO, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.